Comparison
20p12 3 Microdeletion Syndrome C4304539 vs 11p15 4 Microduplication Syndrome C4749508
Clinical comparison between 20p12 3 Microdeletion Syndrome and 11p15 4 Microduplication Syndrome for differential diagnosis and treatment planning.
20p12 3 Microdeletion Syndrome C4304539
A rare chromosomal disorder where a small segment of chromosome 20 is missing. It can cause developmental delays, intellectual disability, and various physical features. Care focuses on symptom management and developmental support.
11p15 4 Microduplication Syndrome C4749508
A rare genetic disorder involving duplication of material on chromosome 11, leading to varied developmental features. Requires individualized medical assessment.
6 comparison axes
Onset
20p12 3 Microdeletion Syndrome C4304539
0-null
11p15 4 Microduplication Syndrome C4749508
0-null
Onset patterns differ
Severity
20p12 3 Microdeletion Syndrome C4304539
severe
11p15 4 Microduplication Syndrome C4749508
moderate
Different severity levels
Chronic
20p12 3 Microdeletion Syndrome C4304539
Chronic
11p15 4 Microduplication Syndrome C4749508
Chronic
Differing course
Communicable
20p12 3 Microdeletion Syndrome C4304539
No
11p15 4 Microduplication Syndrome C4749508
No
Different transmission
Body System
20p12 3 Microdeletion Syndrome C4304539
congenital
11p15 4 Microduplication Syndrome C4749508
congenital
Same/different system
Category
20p12 3 Microdeletion Syndrome C4304539
rare-disease
11p15 4 Microduplication Syndrome C4749508
genetic
Different category
Bottom line
20p12-3-microdeletion-syndrome-C4304539 and 11p15-4-microduplication-syndrome-C4749508 differ in severity, etiology
Key differentiating points
Findings that most reliably separate the two conditions at the bedside or in the workup.
| Feature | 20p12 3 Microdeletion Syndrome C4304539 | 11p15 4 Microduplication Syndrome C4749508 | Discriminating power |
|---|---|---|---|
| Developmental difference | Source links developmental delay and intellectual disability; labeled severe. | Varied developmental features are described; labeled moderate. | Moderate |
| Chromosomal change | Missing material involving 20p12.3. | Extra material involving 11p15.4. | High |
| Physical features | Various physical features are reported but not specified here. | Specific features are not established in the supplied source. | Low |
When to favor each condition
Choose 20p12 3 Microdeletion Syndrome C4304539 when
A confirmed 20p12.3 deletion
The named deletion, not symptoms alone, identifies this condition.
High
Substantial developmental support needs
The supplied severity is severe, although individual course varies.
Moderate
Planning symptom-focused care
The source emphasizes management and developmental support.
Moderate
Choose 11p15 4 Microduplication Syndrome C4749508 when
A confirmed 11p15.4 duplication
The named duplication defines this condition rather than clinical overlap.
High
Variable or apparently milder features
Supplied severity is moderate, but this does not predict every person.
Moderate
Uncertain phenotype after testing
The source calls for individualized assessment without assuming severity.
Moderate
How key tests differ
| Test | 20p12 3 Microdeletion Syndrome C4304539 | 11p15 4 Microduplication Syndrome C4749508 | Interpretation |
|---|---|---|---|
| Chromosomal microarray | May detect a deletion at 20p12.3. | May detect a duplication at 11p15.4. | An abnormal result supports but does not alone establish the syndrome. |
| Standard karyotype | A small deletion may be missed. | A small duplication may be missed. | A normal karyotype excludes neither; higher-resolution testing is more informative. |
| Parental genetic testing | May show de novo or inherited deletion. | May show de novo or inherited duplication. | Inheritance informs counseling; it does not set clinical severity. |
Prognosis comparison
20p12 3 Microdeletion Syndrome C4304539
- Outcome
- Long-term outcome is not established; labeled severity is severe.
- Factors
- Deletion content, anomalies, and therapy access may matter but are unquantified.
11p15 4 Microduplication Syndrome C4749508
- Outcome
- Outcome is variable and not established; labeled severity is moderate.
- Factors
- Duplication content, penetrance, and comorbidities need clinician review.
Time frame: Both are lifelong congenital conditions; exact milestones are not established.
The individual report and serial developmental assessments should guide prognosis.
Complications comparison
| Complication | Presentation |
|---|---|
| Developmental disability | Intellectual disability is described, without a fixed degree. Developmental impact varies and is not quantified here. Compare measured function rather than infer a complication. |
| Congenital anomalies | Various physical features are possible but unspecified. No specific anomaly pattern is established in this source. Clinical screening is appropriate; do not assume a fixed pattern. |
| Family recurrence | Risk depends on parental findings and is not stated here. Risk likewise depends on parental findings. Genetic counseling is appropriate for both conditions. |
Patient education highlights
- HighResult versus diagnosis
An abnormal genetic test needs correlation with examination and development.
- HighSupportive care
No specific cure or dose is established here; care is individualized.
- MediumTransmission
Neither condition is contagious, although either may be inherited.